INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $138,000 | +74.7% | 41,788 | +8.9% | 0.01% | +75.0% |
| Q3 2019 | $79,000 | -48.4% | 38,388 | -26.0% | 0.00% | -55.6% |
| Q2 2019 | $153,000 | +44.3% | 51,874 | +82.1% | 0.01% | +50.0% |
| Q1 2019 | $106,000 | +1.9% | 28,485 | +9.2% | 0.01% | -14.3% |
| Q4 2018 | $104,000 | -43.2% | 26,082 | -10.1% | 0.01% | -22.2% |
| Q3 2017 | $183,000 | -81.8% | 28,998 | -77.5% | 0.01% | -83.0% |
| Q2 2017 | $1,008,000 | -38.9% | 128,698 | -55.0% | 0.05% | -13.1% |
| Q3 2015 | $1,651,000 | +660.8% | 285,743 | +973.5% | 0.06% | +771.4% |
| Q1 2015 | $217,000 | -86.4% | 26,619 | -83.6% | 0.01% | -90.5% |
| Q3 2014 | $1,599,000 | – | 162,388 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |